↓ Skip to main content

The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside

Overview of attention for article published in Frontiers in oncology, January 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside
Published in
Frontiers in oncology, January 2021
DOI 10.3389/fonc.2020.611690
Pubmed ID
Authors

Yimei Feng, Xiaoli Chen, Kaniel Cassady, Zhongmin Zou, Shijie Yang, Zheng Wang, Xi Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 15%
Researcher 6 15%
Student > Ph. D. Student 5 13%
Student > Doctoral Student 4 10%
Lecturer > Senior Lecturer 2 5%
Other 4 10%
Unknown 12 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 26%
Medicine and Dentistry 8 21%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Chemistry 2 5%
Unspecified 1 3%
Other 4 10%
Unknown 12 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2021.
All research outputs
#16,059,145
of 25,387,668 outputs
Outputs from Frontiers in oncology
#5,644
of 22,433 outputs
Outputs of similar age
#290,306
of 519,602 outputs
Outputs of similar age from Frontiers in oncology
#176
of 665 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,433 research outputs from this source. They receive a mean Attention Score of 3.0. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,602 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 665 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.